论文部分内容阅读
目的:探究脑卒中相关性肺炎治疗中应用盐酸氨溴索的临床效果。方法:选取2010年6月-2014年6月在肇庆市鼎湖区永安镇卫生院接受治疗124例脑卒中相关性肺炎患者,随机分为观察组和对照组各62例,对照组采用常规治疗,观察组在常规治疗的基础上给予盐酸氨溴索治疗,对比两组临床疗效。结果:观察组治疗有效率显著高于对照组,组间比较,差异具有统计学意义(P<0.05);观察组患者住院时间、抗生素使用时间、退热时间明显低于对照组,组间比较,差异具有统计学意义(P<0.05);观察组动脉痒分压、C反应蛋白水平与对照组比较,差异无统计学意义(P>0.05)。结论:脑卒中相关性肺炎治疗中应用盐酸氨溴索可以提升治疗效果,缩短住院时间与抗生素使用时间。
Objective: To investigate the clinical effect of ambroxol hydrochloride in the treatment of stroke-associated pneumonia. Methods: From June 2010 to June 2014, 124 stroke-related pneumonia patients in Yongan Town, Dinghu District, Zhaoqing City were randomly divided into observation group (62 cases) and control group (62 cases). The control group was treated with routine therapy, The observation group was treated with ambroxol hydrochloride on the basis of routine treatment, and the clinical efficacy was compared between the two groups. Results: The treatment efficiency in the observation group was significantly higher than that in the control group, the difference was statistically significant (P <0.05); the hospitalization time, antibiotic use time and antipyretic time in the observation group were significantly lower than those in the control group , The difference was statistically significant (P <0.05). There was no significant difference in arterial itch partial pressure and C-reactive protein in the observation group compared with the control group (P> 0.05). Conclusion: The application of ambroxol hydrochloride in the treatment of stroke-associated pneumonia can improve the therapeutic effect, shorten the length of hospital stay and the duration of antibiotics.